TP53 and ovarian cancer: In this study, we demonstrate that PBSA negatively regulates p53‐deficient ovarian cancer cell fates including invasion, adhesion and proliferation, and angiogenic responses such as capillary‐like structure formation and microvessel outgrowth without affecting endothelial cell proliferation or cytotoxicity.